SBEV Q2 2025 Earnings EPS Misses Estimates Amid Ongoing Challenges BioMarin Pharmaceutical Inc BMRN Q1 2026 Earnings EPS Miss Pressures Valuation Yet Stock Edges Higher LAB Q1 2026 Earnings Extreme EPS Surprise Drives Stock Rally NTHI Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Continues RD Investment BRTX Q1 2026 Earnings EPS Surpasses Estimates by Over 41 Shares Rally ASTL Q1 2026 Earnings Significant EPS Beat Amid Challenging Market Conditions ICCM Q1 2026 Earnings EPS Miss as PreRevenue Company Focuses on Commercialization